<DOC>
	<DOCNO>NCT02426164</DOCNO>
	<brief_summary>Liposomal bupivacaine novel local anesthetic design prolonged pain relief . Despite long-acting analgesic potential , liposomal bupivacaine significantly expensive local anesthetic alternative . The primary aim investigation examine whether liposomal bupivacaine provide superior pain relief clinically significant opioid-sparing effect versus control justify cost .</brief_summary>
	<brief_title>Liposomal Bupivacaine Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Patients undergo primary unilateral total knee arthroplasty PI trial Patients sensitivity marcaine Pregnant lactate woman NonEnglish speaking individual</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>